Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

A Randomized Comparison of Oral Methadone as a "First-Switch" Opioid Versus Opioid Switching Between Sustained-Release Morphine and Oxycodone for Oncology-Hematology Outpatients With Pain Management Problems: The "Simply Rotate" Study

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT00726830
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:38:01.411207+00:00
Published At
2012-12-06T00:00:00+00:00
Record Updated At
2020-09-24
Results Posted At
2012-12-06
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Brain and Central Nervous System Tumors", "Chronic Myeloproliferative Disorders", "Leukemia", "Lymphoma", "Lymphoproliferative Disorder", "Multiple Myeloma and Plasma Cell Neoplasm", "Myelodysplastic Syndromes", "Myelodysplastic/Myeloproliferative Neoplasms", "Pain", "Precancerous Condition", "Unspecified Adult Solid Tumor, Protocol Specific"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2020-09-24"
protocolSection.identificationModule.nctId
"NCT00726830"
protocolSection.identificationModule.officialTitle
"A Randomized Comparison of Oral Methadone as a \"First-Switch\" Opioid Versus Opioid Switching Between Sustained-Release Morphine and Oxycodone for Oncology-Hematology Outpatients With Pain Management Problems: The \"Simply Rotate\" Study"
protocolSection.statusModule.overallStatus
"TERMINATED"
protocolSection.designModule.phases
["NA"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
"2012-12-06"

Study condition terms

  • Brain and Central Nervous System Tumors (protocolSection.conditionsModule.conditions)
  • Chronic Myeloproliferative Disorders (protocolSection.conditionsModule.conditions)
  • Leukemia (protocolSection.conditionsModule.conditions)
  • Lymphoma (protocolSection.conditionsModule.conditions)
  • Lymphoproliferative Disorder (protocolSection.conditionsModule.conditions)
  • Multiple Myeloma and Plasma Cell Neoplasm (protocolSection.conditionsModule.conditions)
  • Myelodysplastic Syndromes (protocolSection.conditionsModule.conditions)
  • Myelodysplastic/Myeloproliferative Neoplasms (protocolSection.conditionsModule.conditions)
  • Pain (protocolSection.conditionsModule.conditions)
  • Precancerous Condition (protocolSection.conditionsModule.conditions)
  • Unspecified Adult Solid Tumor, Protocol Specific (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.